BATM Advanced Communications Ltd BVC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX11.25
- Day Range
- GBX11.05–11.20
- 52-Week Range
- GBX10.60–20.00
- Bid/Ask
- GBX0.00 / GBX13.00
- Shares Outstanding
- 340.08M
- Market Cap
- GBX3.76B
- Volume/Avg
- 201,447 / 235,953
Key Statistics
- Price/Earnings (Normalized)
- 96.72
- Price/Sales
- 0.63
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,021
- Website
- https://www.batm.com
Valuation
|
Metric
|
BVC
|
|---|---|
Price/Earnings (Normalized) | 96.72 |
Price/Book Value | 0.80 |
Price/Sales | 0.63 |
Price/Cash Flow | 172.13 |
Price/Earnings
BVC
Financial Strength
|
Metric
|
BVC
|
|---|---|
Quick Ratio | 1.28 |
Current Ratio | 1.95 |
Interest Coverage | 4.79 |
Quick Ratio
BVC
Profitability
|
Metric
|
BVC
|
|---|---|
Return on Assets (Normalized) | −20.03% |
Return on Equity (Normalized) | −32.79% |
Return on Invested Capital (Normalized) | −27.73% |
Return on Assets
BVC
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|^&zWp%@ | LOCK|$^ | $146B | |||
| Becton Dickinson & Co
BDX
| LOCK|ht | LOCK|b!>?p | $49B | |||
| ResMed Inc
RMD
| LOCK|!Z%QB#Lv | LOCK|kGmmn | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|^R$T!Y | LOCK|J?GM | $31B | |||
| Alcon Inc
ALC
| LOCK|<MBl#%! | LOCK|N&>&% | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|<%YVXcv! | LOCK|WN^ | $26B | |||
| Solventum Corp
SOLV
| LOCK|MRXD@%$ | LOCK|?S | $15B | |||
| Baxter International Inc
BAX
| LOCK|wK@ | LOCK|fr@^ | $12B | |||
| Repligen Corp
RGEN
| LOCK|?lRL@zG | LOCK|X?N^ | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|KW!>Sk> | LOCK|z>!D | $10B |
United States